Patent ID: 9345791
Filing Date: 2016-05-24
CPC Classification: A61K,C07C,C07D

Claim Text:
1. A compound of formula (II): or a pharmaceutically acceptable salt thereof, wherein: R′ is selected from the group consisting of —(CH X′ is selected from the group consisting of — Z′ is selected from the group consisting of dansyl, —NH-Cy3, Cy5, Cy5.5, and Cy7, or Z′ is Y′ is selected from the group consisting of O, S, SO, SO n′ is selected from the group consisting of 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, and 20; m′ is selected from the group consisting of 2, 3, 4, 5, 6, 7, 8, 9 and 10; p′ is selected from the group consisting of 1, 2, 3, 4, and 5; q′ is selected from the group consisting of 1, 2, 3, 4, and 5; r′ is selected from the group consisting of 0, 1, 2, 3, 4, and 5; s′ is selected from the group consisting of 6, 7, 8, 9, and 10; t′ is selected from the group consisting of 0 and 1; each of R each of R with the proviso that: when R′ is —(CH when R′ is —(CH